ArticleAmerican journal of cancer research2019

Synergistic effects of SHP2 and PI3K pathway inhibitors in GAB2-overexpressing ovarian cancer.

Bowen Sun et al.PubMed ↗Full text ↗

No numbers read from the abstract.